Kamalakannan Palanichamy

Kamalakannan Palanichamy studies brain cancer, particularly glioblastoma, focusing on why tumors resist treatments like radiation and drug therapies and how tumor cells adapt or survive after treatment. This work involves examining DNA repair processes, cancer cell metabolism, and molecular signals (such as microRNAs) that influence tumor growth and treatment resistance. The research aims to identify new drug combinations and mechanisms that could improve treatment outcomes for glioblastoma and related cancers.

Publication output was low and irregular for several years (including gaps in 2021-2022), then spiked sharply in 2023 before dropping again, suggesting an uneven rather than steadily growing publication pattern.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026